Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Griswold Dp"'
Autor:
Thomas H. Corbett, Griswold Dp
Publikováno v:
Cancer. 36:2441-2444
Colon tumors of mice were induced with 1, 2-dimethylhydrazine, N-nitroso-N-methylurethane, methylnitrosourea, and 4-methyl-N'-nitro-N-nitrosoguanidine. Of 82 transplantation attempts, four were successful, and the four tumors have been maintained as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28ab9201f7575424cbdeb534c3abeb06
https://doi.org/10.1002/1097-0142(197512)36:6<2441::aid-cncr2820360627>3.0.co
https://doi.org/10.1002/1097-0142(197512)36:6<2441::aid-cncr2820360627>3.0.co
Publikováno v:
Cancer Chemotherapy and Pharmacology. 29:190-194
Ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7-ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370 147) is a potent mitotic inhibitor, which has provided the basis for a candidate for clinical trial. As observed with clinically u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64f7e41b96656a5c4bce13261d8c8d04
https://doi.org/10.1007/bf00686251
https://doi.org/10.1007/bf00686251
Autor:
Griswold Dp, Steadman D. Harrison
Publikováno v:
Cancer and Metastasis Reviews. 10:255-261
In this short essay, we have taken the opportunity to review briefly the history of anticancer drug screening, consider the changes that have been made throughout that history, and reflect on the suitability of current screening practices and the mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb89ba434e68d4fe69331ce81db567c3
https://doi.org/10.1007/bf00050796
https://doi.org/10.1007/bf00050796
Publikováno v:
Cancer Chemotherapy and Pharmacology. 25:425-429
Pyrazine diazohydroxide (sodium salt, NSC 361456; PZDH) is a new antitumor drug with relatively broad activity in initial evaluations against murine leukemias, solid tumors, and two human tumor xenografts in vivo. The present studies were designed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41228983da6cc55b8518acf0fdb49996
https://doi.org/10.1007/bf00686053
https://doi.org/10.1007/bf00686053
Publikováno v:
Cancer Chemotherapy and Pharmacology. 31:255-257
The antimicrotubule agent taxol (NSC 125973) has shown clinical antitumor activity against several classically refractory tumors. We developed a drug-resistance profile for taxol using ten drug-resistant P388 leukemias to identify potentially useful
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b157be0cb990bcf3c917a5959468c29
https://doi.org/10.1007/bf00685557
https://doi.org/10.1007/bf00685557
Publikováno v:
Journal of the National Cancer Institute. 84(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd7ec05410d7ac66b9b5f8c920d4dd6d
https://pubmed.ncbi.nlm.nih.gov/1545443
https://pubmed.ncbi.nlm.nih.gov/1545443
Autor:
Wayne K. Anderson, William R. Waud, Steadman D. Harrison, Jacqueline Plowman, Donald J. Dykes, Griswold Dp
Publikováno v:
Cancer chemotherapy and pharmacology. 30(4)
Carmethizole hydrochloride [1-methyl-2-methylthio-4,5-bis(hydroxymethyl)imidazole-4', 5'-bis(N-methylcarbamate)hydrochloride, NSC 602,668; hereafter called carmethizole] is a new antitumor drug that has shown relatively broad activity in initial eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ba83ebcbb5a2e20859e25c514db0a30
https://pubmed.ncbi.nlm.nih.gov/1322803
https://pubmed.ncbi.nlm.nih.gov/1322803
Publikováno v:
Cancer chemotherapy and pharmacology. 27(6)
Since 1978, over 50 clinically useful antitumor drugs or new candidate antitumor agents have been evaluated in vivo against cisplatin-resistant P388 leukemia (P388/DDPt) in our laboratories. Analysis of this data base has yielded insights into the cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c18dec59a8703496b7a12cb31b9346
https://pubmed.ncbi.nlm.nih.gov/1849465
https://pubmed.ncbi.nlm.nih.gov/1849465
Publikováno v:
Cancer. 54:1160-1167
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a23b9812f3c83f9c8e83d2bee38cf741
https://doi.org/10.1002/1097-0142(19840915)54:1+<1160::aid-cncr2820541312>3.0.co
https://doi.org/10.1002/1097-0142(19840915)54:1+<1160::aid-cncr2820541312>3.0.co
Publikováno v:
Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors. 1:411-435
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b6a62a377a95a730dafc969eeff9b2f
https://doi.org/10.1016/0362-5478(77)90004-3
https://doi.org/10.1016/0362-5478(77)90004-3